Sprague John M Insider Trades

Insider Trading History

Track insider trading activity for Sprague John M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
T2 Biosystems
T2 Biosystems TTOO
CFO
Holding Value $360 180,000 shares
Last Trade
Nov 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$144k 180,000 shares
$0.80
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $0.282 141 shares
Last Trade
Feb 24, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$157 29 shares
$5.42
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Feb 24, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$157 29 shares
$5.42
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $0.08 40 shares
Last Trade
Feb 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221 40 shares
$5.52
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $0.224 112 shares
Last Trade
Feb 20, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$221 40 shares
$5.52
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $14.5 7,268 shares
Last Trade
Feb 28, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$70.6k 1,148 shares
$61.50
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $5.83 2,914 shares
Last Trade
Feb 24, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$166k 2,914 shares
$57.00
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $16.8 8,416 shares
Last Trade
Feb 24, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$166k 2,914 shares
$57.00
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $11 5,502 shares
Last Trade
Feb 22, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$95.4k 1,545 shares
$61.76
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $14.1 7,047 shares
Last Trade
Feb 20, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$320k 4,000 shares
$80.00
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $16 8,000 shares
Last Trade
Feb 20, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$320k 4,000 shares
$80.00
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $305 152,350 shares
Last Trade
Apr 08, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$24.2M 10,000 shares
$2,422.00
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $272 136,196 shares
Last Trade
Feb 24, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$123M 55,008 shares
$2,244.00
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $583 291,439 shares
Last Trade
Feb 24, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$327M 145,719 shares
$2,244.00
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $395 197,358 shares
Last Trade
Feb 24, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$327M 145,719 shares
$2,244.00
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $285 142,350 shares
Last Trade
Feb 24, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$123M 55,008 shares
$2,244.00
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $583 291,439 shares
Last Trade
Feb 24, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$327M 145,719 shares
$2,244.00
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $382 191,204 shares
Last Trade
Feb 24, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$327M 145,719 shares
$2,244.00
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $111 55,414 shares
Last Trade
Feb 21, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$23.3M 10,000 shares
$2,333.00
$0.00
T2 Biosystems
T2 Biosystems TTOO
Chief Financial Officer
Holding Value $111 55,414 shares
Last Trade
Feb 21, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$23.3M 10,000 shares
$2,333.00
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up